1 |
Gonzales-Aloy E, Ahmed-Cox A, Tsoli M, Ziegler DS, Kavallaris M. From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer. Adv Drug Deliv Rev 2023;196:114777. [PMID: 36931346 DOI: 10.1016/j.addr.2023.114777] [Reference Citation Analysis]
|
2 |
Trivedi S, Bhoyar V, Akojwar N, Belgamwar V. Transport of nanocarriers to brain for treatment of glioblastoma multiforme: Routes and challenges. Nano Trends 2023;1:100005. [DOI: 10.1016/j.nwnano.2023.100005] [Reference Citation Analysis]
|
3 |
Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N, Huang C, Shen Z. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. J Hematol Oncol 2022;15:132. [PMID: 36096856 DOI: 10.1186/s13045-022-01320-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Sokolova V, Ebel JF, Kollenda S, Klein K, Kruse B, Veltkamp C, Lange CM, Westendorf AM, Epple M. Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell Models. Small 2022;:e2201167. [PMID: 35712760 DOI: 10.1002/smll.202201167] [Reference Citation Analysis]
|
5 |
Foglizzo V, Marchiò S. Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers (Basel) 2022;14:2473. [PMID: 35626078 DOI: 10.3390/cancers14102473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
6 |
Kazemzadeh P, Sayadi K, Toolabi A, Sayadi J, Zeraati M, Chauhan NPS, Sargazi G. Structure-Property Relationship for Different Mesoporous Silica Nanoparticles and its Drug Delivery Applications: A Review. Front Chem 2022;10:823785. [DOI: 10.3389/fchem.2022.823785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|